Shuttle Pharmaceuticals Holdings (SHPH) Financial Statements
Price: $0.366
Market Cap: $2.29M
Avg Volume: 314.01K
Market Cap: $2.29M
Avg Volume: 314.01K
Country: US
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Shuttle Pharmaceuticals Holdings.
Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | $- | $- | $- | $- | $- | $- | $- |
| Cost of Revenue | $- | $6.81K | $66.83K | $60.83K | $54.95K | $18.00K | $18.74K |
| Gross Profit | $- | $-6.81K | $-66.83K | $-60.83K | $-54.95K | $-18.00K | $-18.74K |
| Gross Profit Ratio | 0.00% | - | - | - | - | - | - |
| Research and Development Expenses | $3.62B | $3.52M | $1.49M | $1.02M | $161.77K | $55.57K | $-836 |
| General and Administrative Expenses | $1.39B | $1.05M | $1.07M | $721.18K | $347.75K | $- | $- |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $1.39B | $1.05M | $1.07M | $721.18K | $347.75K | $513.06K | $185.99K |
| Other Expenses | $2.68B | $1.33M | $328.69K | $- | $- | $- | $- |
| Operating Expenses | $7.70B | $5.89M | $2.55M | $1.74M | $509.52K | $568.63K | $185.15K |
| Cost and Expenses | $- | $5.89M | $2.55M | $1.74M | $509.52K | $586.63K | $203.89K |
| Interest Income | $38.14M | $79.12K | $- | $- | $- | $- | $- |
| Interest Expense | $-8.69M | $2.60M | $969.89K | $50.79K | $39.63K | $30.92K | $10.88K |
| Depreciation and Amortization | $1.46B | $6.81K | $5.97K | $60.83K | $54.95K | $18.00K | $18.74K |
| EBITDA | $-7.70B | $-3.99M | $-4.32M | $-1.04M | $-711.15K | $-577.22K | $-183.97K |
| EBITDA Ratio | - | - | - | - | - | - | - |
| Operating Income | $-7.70B | $-5.89M | $-2.55M | $-1.74M | $-509.52K | $-586.63K | $-203.89K |
| Operating Income Ratio | - | - | - | - | - | - | - |
| Total Other Income Expenses Net | $-1.45B | $-700.34K | $-474.17K | $590.86K | $-296.21K | $-39.51K | $-9.70K |
| Income Before Tax | $-9.14B | $-6.59M | $-3.03M | $-1.15M | $-805.73K | $-626.14K | $-213.59K |
| Income Before Tax Ratio | - | - | - | - | - | - | - |
| Income Tax Expense | $- | $- | $71.01K | $50.79K | $39.63K | $- | $1 |
| Net Income | $-9.14B | $-6.59M | $-3.10M | $-1.20M | $-845.36K | $-626.14K | $-213.59K |
| Net Income Ratio | - | - | - | - | - | - | - |
| EPS | $-3186.21 | $-0.41 | $-0.30 | $-0.09 | $-0.06 | $-0.05 | $-0.02 |
| EPS Diluted | $-3167.28 | $-0.41 | $-0.30 | $-0.09 | $-0.06 | $-0.05 | $-0.02 |
| Weighted Average Shares Outstanding | 2.87M | 15.91M | 10.35M | 13.59M | 13.59M | 13.59M | 13.59M |
| Weighted Average Shares Outstanding Diluted | 2.89M | 15.91M | 10.35M | 13.59M | 13.59M | 13.59M | 13.59M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $1.92B | $2.58M | $8.42M | $504.75K | $117.15K | $352.39K | $50.71K |
| Short Term Investments | $- | $2.89M | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $1.92B | $5.46M | $8.42M | $504.75K | $117.15K | $352.39K | $50.71K |
| Net Receivables | $- | $14.90K | $- | $- | $211.46K | $3.83K | $49.21K |
| Inventory | $- | $- | $- | $- | $- | $- | $- |
| Other Current Assets | $290.77M | $114.47K | $161.15K | $4.87K | $12.58K | $257.74K | $2.54K |
| Total Current Assets | $2.21B | $5.59M | $8.58M | $509.62K | $341.19K | $613.96K | $102.46K |
| Property Plant Equipment Net | $295.37K | $358.73K | $68.71K | $135.55K | $196.38K | $838 | $18.84K |
| Goodwill | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- |
| Long Term Investments | $- | $- | $- | $- | $- | $- | $- |
| Tax Assets | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $295.08M | $- | $6.48K | $6.48K | $6.48K | $6.48K | $- |
| Total Non-Current Assets | $295.37M | $358.73K | $75.19K | $142.03K | $202.86K | $7.32K | $18.84K |
| Other Assets | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $2.51B | $5.95M | $8.65M | $651.64K | $544.05K | $621.27K | $121.30K |
| Account Payables | $596.60K | $283.31K | $129.25K | $828.31K | $516.97K | $30.73K | $79.10K |
| Short Term Debt | $1.41B | $648.48K | $811.12K | $916.43K | $686.44K | $400.00K | $314.38K |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $- | $378.56K | $228.39K | $17.54K | $- |
| Other Current Liabilities | $119.61M | $110.45K | $35.31K | $472.58K | $901.56K | $145.54K | $12.16K |
| Total Current Liabilities | $1.53B | $1.04M | $975.68K | $2.22M | $2.10M | $593.82K | $405.65K |
| Long Term Debt | $238.33M | $439.22K | $- | $62.44K | $129.38K | $- | $- |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $25.04M | $414.51K | $- | $- | $- | $- | $- |
| Total Non-Current Liabilities | $263.37M | $853.73K | $865.04K | $62.44K | $129.38K | $- | $- |
| Other Liabilities | $- | $- | $-865.04K | $- | $- | $- | $- |
| Total Liabilities | $1.80B | $1.90M | $975.68K | $2.28M | $2.23M | $593.82K | $405.65K |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $41 | $20 | $136 | $93 | $93 | $179 | $450.00K |
| Retained Earnings | $-34.58B | $-25.43M | $-8.89M | $-5.80M | $-4.54M | $-1.91M | $-1.28M |
| Accumulated Other Comprehensive Income Loss | $- | $- | $- | $16.34K | $16.34K | $16.34K | $- |
| Other Total Stockholders Equity | $35.29B | $29.49M | $26.52M | $4.17M | $2.85M | $1.92M | $550.10K |
| Total Stockholders Equity | $709.15M | $4.06M | $7.68M | $-1.63M | $-1.69M | $27.46K | $-284.35K |
| Total Equity | $709.15M | $4.06M | $7.68M | $-1.63M | $-1.69M | $27.46K | $-284.35K |
| Total Liabilities and Stockholders Equity | $2.51B | $5.95M | $8.65M | $651.64K | $544.05K | $621.27K | $121.30K |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $2.51B | $5.95M | $8.65M | $651.64K | $544.05K | $621.27K | $121.30K |
| Total Investments | $- | $2.89M | $- | $- | $- | $- | $- |
| Total Debt | $1.65B | $1.09M | $748.30K | $978.88K | $815.82K | $400.00K | $314.38K |
| Net Debt | $-268.55M | $-1.49M | $-7.67M | $474.13K | $698.66K | $47.61K | $263.67K |
Cash Flow Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|
| Net Income | $-9.14M | $-6.59M | $-3.03M | $-1.15M | $-805.73K | $-626.14K | $-213.59K |
| Depreciation and Amortization | $5.46M | $6.81K | $66.83K | $60.83K | $54.95K | $18.00K | $18.74K |
| Deferred Income Tax | $- | $- | $- | $-641.65K | $- | $- | $- |
| Stock Based Compensation | $259.74M | $181.96K | $403.96K | $910.07K | $459.59K | $- | $- |
| Change in Working Capital | $138.91K | $220.63K | $-555.21K | $519.15K | $7.78K | $16.65K | $-9.03K |
| Accounts Receivables | $- | $- | $- | $211.46K | $164.93K | $45.38K | $-30.43K |
| Inventory | $- | $- | $- | $- | $- | $- | $- |
| Accounts Payables | $313.30K | $154.06K | $-382.88K | $311.35K | $-51.13K | $-48.37K | $10.58K |
| Other Working Capital | $-174.38K | $66.57K | $-172.32K | $-3.65K | $-106.02K | $19.64K | $10.83K |
| Other Non Cash Items | $-7.58B | $602.17K | $402.41K | $3.39K | $256.58K | $63.79K | $58.51K |
| Net Cash Provided by Operating Activities | $-7.33B | $-5.58M | $-2.71M | $-300.34K | $-26.83K | $-566.69K | $-202.71K |
| Investments in Property Plant and Equipment | $- | $-19.05K | $- | $- | $-10.82K | $- | $- |
| Acquisitions Net | $- | $3.02M | $- | $- | $- | $- | $- |
| Purchases of Investments | $-43.59K | $-3.00M | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $2.96B | $187.90K | $- | $- | $- | $- | $- |
| Other Investing Activities | $-43.54M | $-3.02M | $- | $- | $- | $- | $- |
| Net Cash Used for Investing Activities | $2.92B | $-2.83M | $- | $- | $-10.82K | $- | $- |
| Debt Repayment | $133.46K | $2.92M | $600.72K | $687.93K | $70.07K | $205.87K | $160.52K |
| Common Stock Issued | $3.99M | $2.70M | $10.00M | $- | $- | $912.50K | $100 |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $-402.07K | $- | $- | $- | $- |
| Other Financing Activities | $3.75B | $-345.00K | $428.75K | $- | $- | $-250.00K | $- |
| Net Cash Used Provided by Financing Activities | $3.76B | $2.57M | $10.62M | $687.93K | $70.07K | $868.37K | $160.62K |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $-656.27M | $-5.84M | $7.91M | $387.60K | $32.42K | $301.68K | $-42.09K |
| Cash at End of Period | $1.92B | $2.58M | $8.42M | $504.75K | $117.15K | $352.39K | $50.71K |
| Cash at Beginning of Period | $2.58B | $8.42M | $504.75K | $117.15K | $84.73K | $50.71K | $92.80K |
| Operating Cash Flow | $-7.33B | $-5.58M | $-2.71M | $-300.34K | $-26.83K | $-566.69K | $-202.71K |
| Capital Expenditure | $- | $-19.05K | $- | $- | $-10.82K | $- | $- |
| Free Cash Flow | $-7.33B | $-5.60M | $-2.71M | $-300.34K | $-37.65K | $-566.69K | $-202.71K |